The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Loan | Alive

Total Raised




Last Raised

$1.5M | 2 yrs ago

About OriGene Technologies

OriGene Technologies is a biosciences company dedicated to develop gene centric products and services to improve the quality of healthcare diagnostics and treatments. The Company's collection of gene based products and services are important tools to accelerate the discovery of new diagnostics and drug treatments for better patient care.

OriGene Technologies Headquarter Location

9260 Medical Center Drive Suite 4200

Rockville, Maryland, 20850,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing OriGene Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

OriGene Technologies is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

838 items

Latest OriGene Technologies News

Global CRISPR Market & Competition Landscape 2021-2028 Featuring Profiles of Integrated DNA Technologies, Intellia Therapeutics, Horizon Discovery Group, and Precision Biosciences Among Others

Feb 4, 2022

Dublin, IRELAND Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global CRISPR Market 2021-2028" report has been added to's offering. The global CRISPR market is anticipated to display growth at a CAGR of 20.38% through the projected period of 2021-2028. Factors such as growing lifestyle-oriented diseases and the surging prevalence of genetic diseases are widening the scope of the CRISPR market globally. Additionally, the advancements in gene-based therapy in the agriculture sector, coupled with the increased need for clinical trials, are opening new avenues for the global market over the forecasted period. In contrast, the rising ethical concerns relating to technology use and the absence of healthcare budgets in developing nations hamper the overall development of the CRISPR market. Regional Outlook The Asia-Pacific is estimated to observe the fastest growth in the CRISPR market over the considered phase. This growth can be attributed to the continuous research and development activities across India and China. Moreover, these countries have well-developed agriculture research facilities to develop effective and productive crops. Furthermore, the growing reliance on non-vegetarian foods, such as red meat and seafood, contributes to the market's development over the projected phase. Above all, the rising demand for aquaculture predominantly drives the growth of the CRISPR market across the APAC region. Competitive Outlook The prominent companies in the CRISPR market are Integrated DNA Technologies, Intellia therapeutics, Horizon Discovery Group, Precision Biosciences, Genscript, Novartis International AG, Editas Medicine, Caribou Biosciences Inc, Synthego Corporation, OriGene Technologies Inc, Cellectis Bioresearch SAS, CRISPR therapeutics AG, Addgene, New England Biolabs, and Lonza Group Ltd. Key Topics Covered

OriGene Technologies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

OriGene Technologies Rank

  • Where is OriGene Technologies's headquarters?

    OriGene Technologies's headquarters is located at 9260 Medical Center Drive, Rockville.

  • What is OriGene Technologies's latest funding round?

    OriGene Technologies's latest funding round is Loan.

  • How much did OriGene Technologies raise?

    OriGene Technologies raised a total of $56.12M.

  • Who are the investors of OriGene Technologies?

    Investors of OriGene Technologies include Paycheck Protection Program, Qiming Venture Partners, IDG-Accel Capital, Cathay Capital Private Equity, Walden International and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.